ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Feb 15, 2017
Gilead Sciences Continues Its Meltdown
Image Source: Gilead. Valuentum has been out of Gilead in the newsletter portfolios for some time. As the Best Ideas Newsletter portfolio continues to make new highs, Gilead continues to set new 52-week lows. This is the power of “portfolio thinking,” something we've been preaching for a long time.
Feb 15, 2017
These Medical Instruments Won’t Heal Your Portfolio
The medical instruments industry is a group characterized in part by diversity, and as such, there are ideas of all shapes and sizes. Let’s dig into two overvalued companies in the space and what put them in their current positions.
Feb 15, 2017
Amazon’s Future May Be Rich, But So Is Its Valuation
Amazon continues to disrupt the traditional retail landscape and its cloud-based services are gaining momentum, but shares look to be running ahead of its fundamental trajectory. Let’s take a look at its most recent quarter.
Feb 14, 2017
Is AbbVie a Value Trap?
Image Source: Express Scripts. With uncertainty surrounding the patent of blockbuster drug Humira, AbbVie is looking to deliver another success story from its pipeline. Is it headed for a patent cliff? Let’s take a look.
Feb 13, 2017
Dividend Increases/Decreases for the Week Ending February 10
Let's take a look at the companies that raised/lowered their dividends this week.
Feb 11, 2017
Best Ideas Roundup: Visa, Facebook, Buffalo Wild Wings
Image Source: DeclanTM. Let’s take a look at the recent earnings reports and outlooks for three key holdings in the Best Ideas Newsletter portfolio.
Feb 6, 2017
Dividend Increases/Decreases for the Week Ending February 3
Let's take a look at companies raising/lowering their dividends this week.
Feb 4, 2017
The Bottom Line: Altria’s Translates to Dividend Growth
Image Source: Peyri Herrera. Altria continues to successfully battle a challenging demand environment for cigarette volumes across its industry, and the company has once again rolled out expectations for meaningful earnings-per-share growth in 2017. Altria’s stock is among the best performers in history – find out why.
Feb 3, 2017
Hanesbrands Now Even Cheaper; FCF Yield: ~7%; PE Ratio: ~10x
Image Source: Steven Depolo. Hanesbrands’ management set too high of a bar for itself to hurdle, and while the company put up strong free cash flow performance, we think it set investors up for a disappointment, shattering investor confidence in the executive team’s ability to accurately forecast future trends in its business. Hanesbrands’ stock, however, continues to look cheap by most valuation measures, and free cash flow is expected to remain robust in fiscal 2017, easily covering cash dividends expected to be paid in the year.
Feb 2, 2017
Apple Reports Record Quarterly Results in Return to Top-Line Growth
Newsletter portfolios holding Apple set multiple company records in the first quarter of its fiscal 2017. Let’s take a quick look at the quarter.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.